Mesenchymal stem cells secretory responses: Senescence messaging secretome and immunomodulation perspective

Frontiers in Genetics

Volumn 8, Issue DEC, 2017, Pages

  Lunyak, Victoria V ^a   Amaro Ortiz, Alexandra ^a   Gaur, Meenakshi ^a  

^a Aelan Cell Technologies   (United States)

Author keywords

Inflammasome; Mesenchymal stem cells; SASP; Secretome SMS; Senescence

Indexed keywords

BETA GALACTOSIDASE; CHEMOKINE RECEPTOR CXCR2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR; HISTONE H2AX; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; KRUPPEL LIKE FACTOR 4; LEPTIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; PYRUVATE DEHYDROGENASE; SOMATOMEDIN C RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA;

AGING; CELL STRESS; CELLULAR SECRETION; DNA DAMAGE RESPONSE; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOSENESCENCE; INFLAMMATION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; REVIEW; TISSUE REPAIR;

EID: 85039940872     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2017.00220     Document Type: Review

References (184)

1. Abrahams, V. M., Kamsteeg, M., and Mor, G. (2003). The Fas/Fas ligand system and cancer: immune privilege and apoptosis. Mol. Biotechnol. 25, 19-30. doi: 10.1385/MB:25:1:19
2. Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., et al. (2013). A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978-990. doi: 10.1038/ncb2784
3. Acosta, J. C., O'loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018. doi: 10.1016/j.cell.2008.03.038
4. Aggarwal, S., and Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822. doi: 10.1182/blood-2004-04-1559
5. Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., et al. (2010). A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120, 681-693. doi: 10.1172/JCI40535
6. Andrade-Oliveira, V., Camara, N. O., and Moraes-Vieira, P. M. (2015). Adipokines as drug targets in diabetes and underlying disturbances. J. Diabetes Res. 2015:681612. doi: 10.1155/2015/681612
7. Aso, K., Tsuruhara, A., Takagaki, K., Oki, K., Ota, M., Nose, Y., et al. (2016). Adipose-derived mesenchymal stem cells restore impaired mucosal immune responses in aged mice. PLoS ONE 11:e0148185. doi: 10.1371/journal.pone.0148185
8. Attar-Schneider, O., Zismanov, V., Drucker, L., and Gottfried, M. (2016). Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation. Tumour Biol. 37, 4755-4765. doi: 10.1007/s13277-015-4304-3
9. Bai, L., Lennon, D. P., Caplan, A. I., Dechant, A., Hecker, J., Kranso, J., et al. (2012). Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 15, 862-870. doi: 10.1038/nn.3109
10. Baker, D. J., and Sedivy, J. M. (2013). Probing the depths of cellular senescence. J. Cell Biol. 202, 11-13. doi: 10.1083/jcb.201305155
11. Baroja-Mazo, A., Martin-Sanchez, F., Gomez, A. I., Martinez, C. M., Amores-Iniesta, J., Compan, V., et al. (2014). The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738-748. doi: 10.1038/ni.2919
12. Barthel, S. R., Gavino, J. D., Descheny, L., and Dimitroff, C. J. (2007). Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin. Ther. Targets 11, 1473-1491. doi: 10.1517/14728222.11.11.1473
13. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., Mcintosh, K., Patil, S., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48. doi: 10.1016/S0301-472X(01)00769-X
14. Beeston, T., Smith, T. R., Maricic, I., Tang, X., and Kumar, V. (2010). Involvement of IFN-gamma and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 229, 91-97. doi: 10.1016/j.jneuroim.2010.07.007
15. Ben-Ami, E., Miller, A., and Berrih-Aknin, S. (2014). T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2. Autoimmun. Rev. 13, 187-196. doi: 10.1016/j.autrev.2013.09.007
16. Benvenuto, F., Ferrari, S., Gerdoni, E., Gualandi, F., Frassoni, F., Pistoia, V., et al. (2007). Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25, 1753-1760. doi: 10.1634/stemcells.2007-0068
17. Berezhkovskii, A. M., Coppey, M., Sealfon, S. C., and Shvartsman, S. (2008). Cell-to-cell communication: time and length scales of ligand internalization in cultures of suspended cells. J. Chem. Phys. 128:225102. doi: 10.1063/1.2936845
18. Bernotiene, E., Palmer, G., and Gabay, C. (2006). The role of leptin in innate and adaptive immune responses. Arthritis Res. Ther. 8:217. doi: 10.1186/ar2004
19. Bertoli, C., Skotheim, J. M., and De Bruin, R. A. (2013). Control of cell cycle transcription during G1 and S phases. Nat. Rev. Mol. Cell Biol. 14, 518-528. doi: 10.1038/nrm3629
20. Bien, K., Sobanska, Z., Sokolowska, J., Baska, P., Nowak, Z., Winnicka, A., et al. (2016). A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection. Arch. Virol. 161, 913-928. doi: 10.1007/s00705-015-2746-y
21. Blagosklonny, M. V. (2014). Geroconversion: irreversible step to cellular senescence. Cell Cycle 13, 3628-3635. doi: 10.4161/15384101.2014.985507
22. Bradley, L. M., Watson, S. R., and Swain, S. L. (1994). Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180, 2401-2406. doi: 10.1084/jem.180.6.2401
23. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H., Schlegelberger, B., et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665. doi: 10.1038/nature03841
24. Cai, X., Chen, J., Xu, H., Liu, S., Jiang, Q. X., Halfmann, R., et al. (2014). Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207-1222. doi: 10.1016/j.cell.2014.01.063
25. Capasso, S., Alessio, N., Squillaro, T., Di Bernardo, G., Melone, M. A., Cipollaro, M., et al. (2015). Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells. Oncotarget 6, 39457-39468. doi: 10.18632/oncotarget.6277
26. Carrasco-Garcia, E., Arrizabalaga, O., Serrano, M., Lovell-Badge, R., and Matheu, A. (2015). Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline. Aging Cell 14, 710-714. doi: 10.1111/acel.12343
27. Chen, C. C., Wang, L., Plikus, M. V., Jiang, T. X., Murray, P. J., Ramos, R., et al. (2015). Organ-level quorum sensing directs regeneration in hair stem cell populations. Cell 161, 277-290. doi: 10.1016/j.cell.2015.02.016
28. Chen, H., Shi, B., Feng, X., Kong, W., Chen, W., Geng, L., et al. (2015). Leptin and neutrophil-activating peptide 2 promote mesenchymal stem cell senescence Through activation of the phosphatidylinositol 3-kinase/akt pathway in patients with systemic lupus erythematosus. Arthritis Rheumatol. 67, 2383-2393. doi: 10.1002/art.39196
29. Chen, P. M., Liu, K. J., Hsu, P. J., Wei, C. F., Bai, C. H., Ho, L. J., et al. (2014). Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J. Leukoc. Biol. 96, 295-303. doi: 10.1189/jlb.3A0513-242R
30. Chen, Y., Xiang, L. X., Shao, J. Z., Pan, R. L., Wang, Y. X., Dong, X. J., et al. (2010). Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J. Cell. Mol. Med. 14, 1494-1508. doi: 10.1111/j.1582-4934.2009.00912.x
31. Chen, Z., Trotman, L. C., Shaffer, D., Lin, H. K., Dotan, Z. A., Niki, M., et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730. doi: 10.1038/nature03918
32. Cheng, J., Waite, A. L., Tkaczyk, E. R., Ke, K., Richards, N., Hunt, A. J., et al. (2010). Kinetic properties of ASC protein aggregation in epithelial cells. J. Cell. Physiol. 222, 738-747. doi: 10.1002/jcp.22005
33. Chiche, A., Le Roux, I., Von Joest, M., Sakai, H., Aguin, S. B., Cazin, C., et al. (2017). Injury-induced senescence enables in vivo reprogramming in skeletal muscle. Cell Stem Cell 20, 407.e4-414.e4. doi: 10.1016/j.stem.2016.11.020
34. Childs, B. G., Durik, M., Baker, D. J., and Van Deursen, J. M. (2015). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med. 21, 1424-1435. doi: 10.1038/nm.4000
35. Conradt, B. (2009). Genetic control of programmed cell death during animal development. Annu. Rev. Genet. 43, 493-523. doi: 10.1146/annurev.genet.42.110807.091533
36. Coppe, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., et al. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868. doi: 10.1371/journal.pbio.0060301
37. Correia-Melo, C., and Passos, J. F. (2015). Mitochondria: are they causal players in cellular senescence? Biochim. Biophys. Acta 1847, 1373-1379. doi: 10.1016/j.bbabio.2015.05.017
38. D'Adda di fagagna, F. (2008). Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 8, 512-522. doi: 10.1038/nrc2440
39. De Cecco, M., Criscione, S. W., Peckham, E. J., Hillenmeyer, S., Hamm, E. A., Manivannan, J., et al. (2013). Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12, 247-256. doi: 10.1111/acel.12047
40. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684. doi: 10.1016/0092-8674(95)90039-X
41. De Rosa, V., Procaccini, C., Cali, G., Pirozzi, G., Fontana, S., Zappacosta, S., et al. (2007). A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255. doi: 10.1016/j.immuni.2007.01.011
42. Dhomen, N., Reis-Filho, J. S., Da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., et al. (2009). Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15, 294-303. doi: 10.1016/j.ccr.2009.02.022
43. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843. doi: 10.1182/blood. V99.10.3838
44. Dirac, A. M., and Bernards, R. (2003). Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278, 11731-11734. doi: 10.1074/jbc. C300023200
45. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., et al. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023. doi: 10.1016/0092-8674(94)90379-4
46. Dulic, V., Stein, G. H., Far, D. F., and Reed, S. I. (1998). Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18, 546-557. doi: 10.1128/MCB.18.1.546
47. Eggenhofer, E., Luk, F., Dahlke, M. H., and Hoogduijn, M. J. (2014). The life and fate of mesenchymal stem cells. Front. Immunol. 5:148. doi: 10.3389/fimmu.2014.00148
48. el-Deiry, W. S., Harper, J. W., O'connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174
49. Ewald, J. A., Desotelle, J. A., Wilding, G., and Jarrard, D. F. (2010). Therapy-induced senescence in cancer. J. Natl. Cancer Inst. 102, 1536-1546. doi: 10.1093/jnci/djq364
50. Fantuzzi, G., and Faggioni, R. (2000). Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68, 437-446
51. Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., et al. (2014). The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat. Immunol. 15, 727-737. doi: 10.1038/ni.2913
52. Freund, A., Orjalo, A. V., Desprez, P. Y., and Campisi, J. (2010). Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16, 238-246. doi: 10.1016/j.molmed.2010.03.003
53. Fuchs, Y., and Steller, H. (2011). Programmed cell death in animal development and disease. Cell 147, 742-758. doi: 10.1016/j.cell.2011.10.033
54. Garbers, C., Thaiss, W., Jones, G. W., Waetzig, G. H., Lorenzen, I., Guilhot, F., et al. (2011). Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J. Biol. Chem. 286, 42959-42970. doi: 10.1074/jbc. M111.295758
55. Gardner, S. E., Humphry, M., Bennett, M. R., and Clarke, M. C. (2015). Senescent vascular smooth muscle cells drive inflammation through an interleukin-1a-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963-1974. doi: 10.1161/ATVBAHA.115.305896
56. Gaur, M., Dobke, M., and Lunyak, V. V. (2017a). Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging. Int. J. Mol. Sci. 18:208. doi: 10.3390/ijms18010208
57. Gaur, M., Wang, L., Amaro-Ortiz, A., Dobke, M., King Jordan, I., and Lunyak, V. V. (2017b). Acute genotoxic stress-induced senescence in human mesenchymal cells drives a unique composition of senescence messaging secretome (SMS). J. Stem Cell Res. Ther. 7:396. doi: 10.4172/2157-7633.1000396
58. Gil, J., and Peters, G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677. doi: 10.1038/nrm1987
59. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., and Dazzi, F. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821-2827. doi: 10.1182/blood-2004-09-3696
60. Gronski, M. A., and Weinem, M. (2006). Death pathways in T cell homeostasis and their role in autoimmune diabetes. Rev. Diabet. Stud. 3, 88-95. doi: 10.1900/RDS.2006.3.88
61. Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., and Ostrand-Rosenberg, S. (2009). Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J. Immunol. 183, 937-944. doi: 10.4049/jimmunol.0804253
62. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. (1996). Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859-867. doi: 10.1128/MCB.16.3.859
63. Hass, R., Kasper, C., Bohm, S., and Jacobs, R. (2011). Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 9:12. doi: 10.1186/1478-811X-9-12
64. Hayflick, L., and Moorhead, P. S. (1961). The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621. doi: 10.1016/0014-4827(61)90192-6
65. Herbig, U., Jobling, W. A., Chen, B. P., Chen, D. J., and Sedivy, J. M. (2004). Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501-513. doi: 10.1016/S1097-2765(04)00256-4
66. Hochane, M., Trichet, V., Pecqueur, C., Avril, P., Oliver, L., Denis, J., et al. (2017). Low-dose pesticide mixture induces senescence in normal mesenchymal stem cells (MSC) and promotes tumorigenic phenotype in premalignant, MSC. Stem Cells 35, 800-811. doi: 10.1002/stem.2539
67. Hoenicke, L., and Zender, L. (2012). Immune surveillance of senescent cells-biological significance in cancer-and non-cancer pathologies. Carcinogenesis 33, 1123-1126. doi: 10.1093/carcin/bgs124
68. Hogg, N., and Landis, R. C. (1993). Adhesion molecules in cell interactions. Curr. Opin. Immunol. 5, 383-390. doi: 10.1016/0952-7915(93)90057-Y
69. Holgate, S. T., Davies, D. E., Lackie, P. M., Wilson, S. J., Puddicombe, S. M., and Lordan, J. L. (2000). Epithelial-mesenchymal interactions in the pathogenesis of asthma. J. Allergy Clin. Immunol. 105, 193-204. doi: 10.1016/S0091-6749(00)90066-6
70. Ichim, T. E., Alexandrescu, D. T., Solano, F., Lara, F., Campion Rde, N., Paris, E., et al. (2010). Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell. Immunol. 260, 75-82. doi: 10.1016/j.cellimm.2009.10.006
71. Iikuni, N., Lam, Q. L., Lu, L., Matarese, G., and La Cava, A. (2008). Leptin and inflammation. Curr. Immunol. Rev. 4, 70-79. doi: 10.2174/157339508784325046
72. Ishiguro, N., and Yoshida, H. (2016). ASPL-TFE3 Oncoprotein regulates cell cycle progression and induces cellular senescence by up-regulating p21. Neoplasia 18, 626-635. doi: 10.1016/j.neo.2016.08.001
73. Jacobson, B. A., Rothstein, T. L., and Marshak-Rothstein, A. (1996). The role of Fas/FasL interactions in the regulation of B cell function. Behring Inst. Mitt. 185-199
74. Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., et al. (2006). Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421-426. doi: 10.1038/nature05159
75. Jiang, Y., Berry, D. C., Tang, W., and Graff, J. M. (2014). Independent stem cell lineages regulate adipose organogenesis and adipose homeostasis. Cell Rep. 9, 1007-1022. doi: 10.1016/j.celrep.2014.09.049
76. Jones, G. W., Mcloughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., et al. (2010). Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J. Immunol. 184, 2130-2139. doi: 10.4049/jimmunol.0901528
77. Jostock, T., Mullberg, J., Ozbek, S., Atreya, R., Blinn, G., Voltz, N., et al. (2001). Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268, 160-167. doi: 10.1046/j.1432-1327.2001.01867.x
78. Jutila, M. A., Watts, G., Walcheck, B., and Kansas, G. S. (1992). Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. J. Exp. Med. 175, 1565-1573. doi: 10.1084/jem.175.6.1565
79. Kang, T. W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., et al. (2011). Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551. doi: 10.1038/nature10599
80. Kansas, G. S. (1996). Selectins and their ligands: current concepts and controversies. Blood 88, 3259-3287
81. Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., MacKay, G., et al. (2013). A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498, 109-112. doi: 10.1038/nature12154
82. Keelan, E. T., Licence, S. T., Peters, A. M., Binns, R. M., and Haskard, D. O. (1994). Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am. J. Physiol. 266, H278-H290
83. Kortlever, R. M., Higgins, P. J., and Bernards, R. (2006). Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8, 877-884. doi: 10.1038/ncb1448
84. Kourtis, N., and Tavernarakis, N. (2007). Non-developmentally programmed cell death in Caenorhabditis elegans. Semin. Cancer Biol. 17, 122-133. doi: 10.1016/j.semcancer.2006.11.004
85. Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., et al. (2008). Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667. doi: 10.1016/j.cell.2008.06.049
86. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y., and Campisi, J. (2001). Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U.S.A. 98, 12072-12077. doi: 10.1073/pnas.211053698
87. Kuilman, T., Michaloglou, C., Mooi, W. J., and Peeper, D. S. (2010). The essence of senescence. Genes Dev. 24, 2463-2479. doi: 10.1101/gad.1971610
88. Kuilman, T., Michaloglou, C., Vredeveld, L. C., Douma, S., Van Doorn, R., Desmet, C. J., et al. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031. doi: 10.1016/j.cell.2008.03.039
89. Kuilman, T., and Peeper, D. S. (2009). Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81-94. doi: 10.1038/nrc2560
90. Lam, Q. L., and Lu, L. (2007). Role of leptin in immunity. Cell Mol. Immunol. 4, 1-13
91. Lasry, A., and Ben-Neriah, Y. (2015). Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 36, 217-228. doi: 10.1016/j.it.2015.02.009
92. Lauffenburger, D. A., Linderman, J., and Berkowitz, L. (1987). Analysis of mammalian cell growth factor receptor dynamics. Ann. N.Y. Acad. Sci. 506, 147-162. doi: 10.1111/j.1749-6632.1987.tb23816.x
93. Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., et al. (1999). Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274, 7936-7940. doi: 10.1074/jbc.274.12.7936
94. Ley, K. (2003). The role of selectins in inflammation and disease. Trends Mol. Med. 9, 263-268. doi: 10.1016/S1471-4914(03)00071-6
95. Ley, K., and Kansas, G. S. (2004). Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4, 325-335. doi: 10.1038/nri1351
96. Ley, K., and Tedder, T. F. (1995). Leukocyte interactions with vascular endothelium. new insights into selectin-mediated attachment and rolling. J. Immunol. 155, 525-528
97. Lin, I. T., Chao, J. L., and Yao, M. C. (2012). An essential role for the DNA breakage-repair protein Ku80 in programmed DNA rearrangements in Tetrahymena thermophila. Mol. Biol. Cell 23, 2213-2225. doi: 10.1091/mbc. E11-11-0952
98. Liu, D., and Hornsby, P. J. (2007). Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117-3126. doi: 10.1158/0008-5472.CAN-06-3452
99. Liu, R., Chang, W., Wei, H., and Zhang, K. (2016). Comparison of the biological characteristics of mesenchymal stem cells derived from bone marrow and skin. Stem Cells Int. 2016:3658798. doi: 10.1155/2016/3658798
100. Loffreda, S., Yang, S. Q., Lin, H. Z., Karp, C. L., Brengman, M. L., Wang, D. J., et al. (1998). Leptin regulates proinflammatory immune responses. FASEB J. 12, 57-65
101. Lopez, M. F., Niu, P., Wang, L., Vogelsang, M., Gaur, M., Krastins, B., et al. (2017). Opposing activities of oncogenic MIR17HG and tumor suppressive MIR100HG clusters and their gene targets regulate replicative senescence in human adult stem cells. NPJ Aging Mech. Dis. 3:7. doi: 10.1038/s41514-017-0006-y
102. Lopez, M. F., Tollervey, J., Krastins, B., Garces, A., Sarracino, D., Prakash, A., et al. (2012). Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells. Aging 4, 823-842. doi: 10.18632/aging.100507
103. Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., et al. (2013). Non-cell-autonomous tumor suppression by p53. Cell 153, 449-460. doi: 10.1016/j.cell.2013.03.020
104. MacLeod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., et al. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944. doi: 10.1101/gad.9.8.935
105. Marlin, S. D., and Springer, T. A. (1987). Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51, 813-819. doi: 10.1016/0092-8674(87)90104-8
106. Meng, Y., Efimova, E. V., Hamzeh, K. W., Darga, T. E., Mauceri, H. J., Fu, Y. X., et al. (2012). Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. Mol. Ther. 20, 1046-1055. doi: 10.1038/mt.2012.19
107. Michaloglou, C., Vredeveld, L. C., Soengas, M. S., Denoyelle, C., Kuilman, T., Van Der Horst, C. M., et al. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724. doi: 10.1038/nature03890
108. Mosteiro, L., Pantoja, C., Alcazar, N., Marion, R. M., Chondronasiou, D., Rovira, M., et al. (2016). Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 354:aaf4445. doi: 10.1126/science.aaf4445
109. Mullberg, J., Dittrich, E., Graeve, L., Gerhartz, C., Yasukawa, K., Taga, T., et al. (1993). Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 332, 174-178. doi: 10.1016/0014-5793(93)80507-Q
110. Munoz-Espin, D., Canamero, M., Maraver, A., Gomez-Lopez, G., Contreras, J., Murillo-Cuesta, S., et al. (2013). Programmed cell senescence during mammalian embryonic development. Cell 155, 1104-1118. doi: 10.1016/j.cell.2013.10.019
111. Murphy, M. B., Moncivais, K., and Caplan, A. I. (2013). Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 45:e54. doi: 10.1038/emm.2013.94
112. Nardella, C., Clohessy, J. G., Alimonti, A., and Pandolfi, P. P. (2011). Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 11, 503-511. doi: 10.1038/nrc3057
113. Narita, M., Nunez, S., Heard, E., Lin, A. W., Hearn, S. A., Spector, D. L., et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716. doi: 10.1016/S0092-8674(03)00401-X
114. Nicolay, N. H., Lopez Perez, R., Saffrich, R., and Huber, P. E. (2015). Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic. Oncotarget 6, 19366-19380. doi: 10.18632/oncotarget.4358
115. Niculescu, A. B. III., Chen, X., Smeets, M., Hengst, L., Prives, C., and Reed, S. I. (1998). Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-643. doi: 10.1128/MCB.18.1.629
116. Niu, P., Smagul, A., Wang, L., Sadvakas, A., Sha, Y., Perez, L. M., et al. (2015). Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence. Oncotarget 6, 17938-17957. doi: 10.18632/oncotarget.4852
117. Nolz, J. C., and Harty, J. T. (2011). Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity 34, 781-793. doi: 10.1016/j.immuni.2011.03.020
118. Nowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., et al. (2009). Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J. Immunol. 182, 613-622. doi: 10.4049/jimmunol.182.1.613
119. O'cearbhaill, E. D., Punchard, M. A., Murphy, M., Barry, F. P., Mchugh, P. E., and Barron, V. (2008). Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials 29, 1610-1619. doi: 10.1016/j.biomaterials.2007.11.042
120. Ohtani, N., and Hara, E. (2013). Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci. 104, 525-530. doi: 10.1111/cas.12118
121. Ozcan, S., Alessio, N., Acar, M. B., Mert, E., Omerli, F., Peluso, G., et al. (2016). Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses. Aging 8, 1316-1329. doi: 10.18632/aging.100971
122. Palomo, J., Dietrich, D., Martin, P., Palmer, G., and Gabay, C. (2015). The interleukin (IL)-1 cytokine family-Balance between agonists and antagonists in inflammatory diseases. Cytokine 76, 25-37. doi: 10.1016/j.cyto.2015.06.017
123. Passos, J. F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., et al. (2007). Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 5:e110. doi: 10.1371/journal.pbio.0050110
124. Patel, P. L., Suram, A., Mirani, N., Bischof, O., and Herbig, U. (2016). Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence. Proc. Natl. Acad. Sci. U.S.A. 113, E5024-E5033. doi: 10.1073/pnas.1602379113
125. Peelman, F., Van Beneden, K., Zabeau, L., Iserentant, H., Ulrichts, P., Defeau, D., et al. (2004). Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem. 279, 41038-41046. doi: 10.1074/jbc. M404962200
126. Perez-Perez, A., Vilarino-Garcia, T., Fernandez-Riejos, P., Martin-Gonzalez, J., Segura-Egea, J. J., and Sanchez-Margalet, V. (2017). Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev. 35, 71-84. doi: 10.1016/j.cytogfr.2017.03.001
127. Pitiyage, G. N., Slijepcevic, P., Gabrani, A., Chianea, Y. G., Lim, K. P., Prime, S. S., et al. (2011). Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J. Pathol. 223, 604-617. doi: 10.1002/path.2839
128. Ponte, A. L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., et al. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737-1745. doi: 10.1634/stemcells.2007-0054
129. Pradillo, J. M., Murray, K. N., Coutts, G. A., Moraga, A., Oroz-Gonjar, F., Boutin, H., et al. (2017). Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia. Brain Behav. Immun. 61, 117-126. doi: 10.1016/j.bbi.2016.11.013
130. Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., et al. (2013). A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 24, 242-256. doi: 10.1016/j.ccr.2013.06.005
131. Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., et al. (2008). Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111, 1021-1028. doi: 10.1182/blood-2007-07-102137
132. Rajagopalan, S., and Long, E. O. (2012). Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl. Acad. Sci. U.S.A. 109, 20596-20601. doi: 10.1073/pnas.1208248109
133. Rao, M. S., and Mattson, M. P. (2001). Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 122, 713-734. doi: 10.1016/S0047-6374(01)00224-X
134. Raouf, S., Weston, C., Yucel, N., and Reproducibility Project: Cancer Biology. (2015). Registered report: senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Elife 4:e04105. doi: 10.7554/eLife.04105
135. Rathinam, V. A., and Fitzgerald, K. A. (2016). Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792-800. doi: 10.1016/j.cell.2016.03.046
136. Reaper, P. M., Di Fagagna, F., and Jackson, S. P. (2004). Activation of the DNA damage response by telomere attrition: a passage to cellular senescence. Cell Cycle 3, 543-546. doi: 10.4161/cc.3.5.835
137. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., et al. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141-150. doi: 10.1016/j.stem.2007.11.014
138. Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., et al. (2017). The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 31, 172-183. doi: 10.1101/gad.290635.116
139. Rodier, F., Coppe, J. P., Patil, C. K., Hoeijmakers, W. A., Munoz, D. P., Raza, S. R., et al. (2009). Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979. doi: 10.1038/ncb1909
140. Rubtsova, M. P., Vasilkova, D. P., Malyavko, A. N., Naraikina, Y. V., Zvereva, M. I., and Dontsova, O. A. (2012). Telomere lengthening and other functions of telomerase. Acta Nat. 4, 44-61
141. Rumman, M., Dhawan, J., and Kassem, M. (2015). Concise review: quiescence in adult stem cells: biological significance and relevance to tissue regeneration. Stem Cells 33, 2903-2912. doi: 10.1002/stem.2056
142. Sage, J., Miller, A. L., Perez-Mancera, P. A., Wysocki, J. M., and Jacks, T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228. doi: 10.1038/nature01764
143. Sagiv, A., Burton, D. G., Moshayev, Z., Vadai, E., Wensveen, F., Ben-Dor, S., et al. (2016). NKG2D ligands mediate immunosurveillance of senescent cells. Aging 8, 328-344. doi: 10.18632/aging.100897
144. Salama, R., Sadaie, M., Hoare, M., and Narita, M. (2014). Cellular senescence and its effector programs. Genes Dev. 28, 99-114. doi: 10.1101/gad.235184.113
145. Salmaso, C., Bagnasco, M., Pesce, G., Montagna, P., Brizzolara, R., Altrinetti, V., et al. (2002). Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann. N.Y. Acad. Sci. 966, 496-501. doi: 10.1111/j.1749-6632.2002.tb04253.x
146. Schmidt-Ullrich, R., Aebischer, T., Hulsken, J., Birchmeier, W., Klemm, U., and Scheidereit, C. (2001). Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development 128, 3843-3853
147. Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., et al. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346. doi: 10.1016/S0092-8674(02)00734-1
148. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832. doi: 10.1016/j.cell.2010.01.040
149. Serrano, M., Lin, A. W., Mccurrach, M. E., Beach, D., and Lowe, S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602. doi: 10.1016/S0092-8674(00)81902-9
150. Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., et al. (2009). Rb regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15, 255-269. doi: 10.1016/j.ccr.2009.03.001
151. Shao, L., Wang, Y., Chang, J., Luo, Y., Meng, A., and Zhou, D. (2013). Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury. Transl. Cancer Res. 2, 397-411. doi: 10.3978/j.issn.2218-676X.2013.07.03
152. Sharma, D., and Kanneganti, T. D. (2016). The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation. J. Cell Biol. 213, 617-629. doi: 10.1083/jcb.201602089
153. Sherr, C. J., and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512. doi: 10.1101/gad.13.12.1501
154. Signer, R. A., and Morrison, S. J. (2013). Mechanisms that regulate stem cell aging and life span. Cell Stem Cell 12, 152-165. doi: 10.1016/j.stem.2013.01.001
155. Singer, N. G., and Caplan, A. I. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457-478. doi: 10.1146/annurev-pathol-011110-130230
156. Smith, J. R., and Pereira-Smith, O. M. (1996). Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63-67. doi: 10.1126/science.273.5271.63
157. Spees, J. L., Lee, R. H., and Gregory, C. A. (2016). Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res. Ther. 7:125. doi: 10.1186/s13287-016-0363-7
158. Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314. doi: 10.1016/0092-8674(94)90337-9
159. Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., et al. (2013). Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119-1130. doi: 10.1016/j.cell.2013.10.041
160. Stremmel, C., Sienel, W., Eggeling, S., Passlick, B., and Slavin, A. (2006). Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice. Eur. J. Cardiothorac. Surg. 30, 362-369. doi: 10.1016/j.ejcts.2006.04.014
161. Strowig, T., Henao-Mejia, J., Elinav, E., and Flavell, R. (2012). Inflammasomes in health and disease. Nature 481, 278-286. doi: 10.1038/nature10759
162. Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S., Tahara, H., Nakayama, K., et al. (2006). Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8, 1291-1297. doi: 10.1038/ncb1491
163. Takashima, Y., Era, T., Nakao, K., Kondo, S., Kasuga, M., Smith, A. G., et al. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129, 1377-1388. doi: 10.1016/j.cell.2007.04.028
164. Tian, Z., Sun, R., Wei, H., and Gao, B. (2002). Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 298, 297-302. doi: 10.1016/S0006-291X(02)02462-2
165. Tschaharganeh, D. F., Xue, W., Calvisi, D. F., Evert, M., Michurina, T. V., Dow, L. E., et al. (2014). p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 158, 579-592. doi: 10.1016/j.cell.2014.05.051
166. Tsuruhara, A., Aso, K., Tokuhara, D., Ohori, J., Kawabata, M., Kurono, Y., et al. (2017). Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells. Int. Immunol. 29, 5-10. doi: 10.1093/intimm/dxx001
167. Uccelli, A., Moretta, L., and Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736. doi: 10.1038/nri2395
168. Varga, J., De Oliveira, T., and Greten, F. R. (2014). The architect who never sleeps: tumor-induced plasticity. FEBS Lett. 588, 2422-2427. doi: 10.1016/j.febslet.2014.06.019
169. Voss, M., Lettau, M., Paulsen, M., and Janssen, O. (2008). Posttranslational regulation of Fas ligand function. Cell Commun. Signal. 6:11. doi: 10.1186/1478-811X-6-11
170. Vredeveld, L. C., Possik, P. A., Smit, M. A., Meissl, K., Michaloglou, C., Horlings, H. M., et al. (2012). Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 26, 1055-1069. doi: 10.1101/gad.187252.112
171. Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., and Green, M. R. (2008). Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132, 363-374. doi: 10.1016/j.cell.2007.12.032
172. Wang, H. W., Babic, A. M., Mitchell, H. A., Liu, K., and Wagner, D. D. (2005). Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. FASEB J. 19, 1018-1020. doi: 10.1096/fj.04-3094fje
173. Wang, J., Geesman, G. J., Hostikka, S. L., Atallah, M., Blackwell, B., Lee, E., et al. (2011). Inhibition of activated pericentromeric SINE/Alu repeat transcription in senescent human adult stem cells reinstates self-renewal. Cell Cycle 10, 3016-3030. doi: 10.4161/cc.10.17.17543
174. Wang, J., Kobayashi, T., Floc'h, N., Kinkade, C. W., Aytes, A., Dankort, D., et al. (2012). B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer. Cancer Res. 72, 4765-4776. doi: 10.1158/0008-5472.CAN-12-0820
175. Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L. X., Cohen, P. A., et al. (2008). Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 181, 3291-3300. doi: 10.4049/jimmunol.181.5.3291
176. Xing, Y., and Hogquist, K. A. (2012). T-cell tolerance: central and peripheral. Cold Spring Harb. Perspect. Biol. 4:a006957. doi: 10.1101/cshperspect.a006957
177. Xue, Q., Luan, X. Y., Gu, Y. Z., Wu, H. Y., Zhang, G. B., Yu, G. H., et al. (2010). The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells Dev. 19, 27-38. doi: 10.1089/scd.2009.0076
178. Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., et al. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660. doi: 10.1038/nature05529
179. Yi, T., and Song, S. U. (2012). Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch. Pharm. Res. 35, 213-221. doi: 10.1007/s12272-012-0202-z
180. Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., et al. (2013). Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101. doi: 10.1038/nature12347
181. Zabeau, L., Lavens, D., Peelman, F., Eyckerman, S., Vandekerckhove, J., and Tavernier, J. (2003). The ins and outs of leptin receptor activation. FEBS Lett. 546, 45-50. doi: 10.1016/S0014-5793(03)00440-X
182. Zhang, H. S., Postigo, A. A., and Dean, D. C. (1999). Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97, 53-61. doi: 10.1016/S0092-8674(00)80714-X
183. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi: 10.1038/372425a0
184. Zhang, Y., Tomann, P., Andl, T., Gallant, N. M., Huelsken, J., Jerchow, B., et al. (2009). Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev. Cell 17, 49-61. doi: 10.1016/j.devcel.2009.05.011